Evidence map›Paper›PMID 41610305›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Record-High Performance Hyperfluorescent OLEDs Achieved via Electronic Structure Control of Chlorine-Diversified MR-TADF Emitters.

Taehwan Lee, Junki Ochi, Shigetada Uemura, Feiran Liu, Jiping Hao, Yasuhiro Kondo, Masahiro Hayakawa, Takuji Hatakeyama

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Taehwan LeeDepartment of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0000-0003-2902-165X
Junki OchiDepartment of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0000-0003-4275-3898
Shigetada UemuraDepartment of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan.
Feiran LiuDepartment of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan.
Jiping HaoDepartment of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0000-0003-2612-9278
Yasuhiro KondoSK JNC Japan Co., Ltd., Chiba, Ichihara, Japan.
Masahiro HayakawaDepartment of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0000-0002-2405-9897
Takuji HatakeyamaDepartment of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0000-0002-7483-9525

Funding

Grants-in-Aid for Scientific Research 24K01569Japan Science and Technology Agency JPMJCR22B3Japan Society for the Promotion of ScienceJoint International Research 23K20039
6 · The paper itself

Abstract

Multiple-resonance (MR)-type thermally activated delayed fluorescence (TADF) emitters enable highly efficient and narrowband organic light-emitting diodes (OLEDs), yet their electronic tunability has remained limited. Here, we demonstrate that chlorine-enabled late-stage diversification of the MR scaffold ω-DABNA allows systematic control of ionization potential and electron affinity, leading to record-high performance in hyperfluorescent (HF) OLEDs. Three derivatives, ω-DABNA-4TBP, ω-DABNA-4CzP, and ω-DABNA-4CNP, were synthesized via a single-step Suzuki-Miyaura coupling, exhibiting narrowband green emission (FWHM = 23-26 nm) and remarkably high horizontal orientation (Θ

Indexed as

hyperfluorescencelate‐stage diversificationmulti‐resonance effectorganic light‐emitting diodethermally activated delayed fluorescence

Identifiers

PMID41610305
PMCPMC13067835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.